Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« And Another Thing. . . | Main | Well Deserved »

October 2, 2005

A Piece of the Action

Email This Entry

Posted by Derek

Does anyone know where a man can put some of his hard-earned research dollars down on a Nobel Prize bet? The Chemistry prize is going to be announced early on Wednesday, so time is tight.

Last year there was a German site taking bets, but they seem dormant. Here's their previous chemistry prize page, which will do for a list of potential names this year, too, since none of them delivered. It's a bit top-heavy with organic chemistry names, I'd say, which is perhaps one reason it didn't perform that well. The Chemistry prize is often used as a way to spread the Medicine (or Physics) prizes around a bit - I'd think a smart customer would want to cover some of those possibilities with a field bet.

But where? Money can be placed on the Peace and Literature prizes. That's understandable, since many more people feel as if they know something about these subjects. (Some of the past awardees make it painfully clear that you don't have to know anything about either one). You can place an interesting bet on a future Physics prize (or lack of one) here. But sporting chemists seem to have no place to turn. . .

Comments (11) + TrackBacks (0) | Category: Current Events


COMMENTS

1. The Novice Chemist on October 2, 2005 11:13 PM writes...

You'd think that Grubbs and Schrock would be up there, but when are they due? First JACS article was 1991; is that long enough time to float to the top of the list?

Permalink to Comment

2. Complex Guy on October 3, 2005 12:22 AM writes...

Frank Westheimer invented molecular modeling (stop snickering, Derek!). Martin Karplus. Harden McConnell. If the Germans are going to put Pete Schultz on there, then Stuart Schreiber should have a spot. Carl Djerassi might surprise everyone. But, Derek's right about covering some biological bases to be safe. Roger Tsien is arguably the synthetic chemist who has had the largest impact on biological sciences. There's the whole RNA thing (RNAi and microRNA, etc.), but I'm sure Derek will cover that again. Ribosome, anyone? The Yale structural group along with Noller at Santa Cruz. Whitesides would be an inspired choice, but what would they cite? Making water run uphill??? No, I think they give the chemistry prize to actual chemists about once every four years. The last three years were mass spec, ion channels, and the proteasome, so we may be due for an actual chemist.

Permalink to Comment

3. Greg Hlatky on October 3, 2005 9:01 AM writes...

One thing you can be sure of: no inorganic chemist will win it this year. None has since Taube in 1983. So cross Grubbs, Schrock, Marks, Brintzinger, Gray and Bergman off the list. You can even cross off Al Cotton, who's been lusting for it for time immemorial.

Nicolau or Schreiber is my guess.

Permalink to Comment

4. toby on October 3, 2005 9:48 AM writes...

In theory tradesports.com lets you create a "contract" on any bet you want. Only problem is that you have to find someone to take the other side of it. Since the contracts there are heavily weighted towards sports and politics, there might not be too many users betting on the Nobel prize -- may be worth a shot though.

Permalink to Comment

5. The Novice Chemist on October 3, 2005 10:19 AM writes...

I would pay a goodly amount of money (say, five dollars) to hear a ten minute sales pitch as to why KCN deserves the chemistry Nobel.


It seems that when organic chemists win the Nobel, it's for fundamental contributions (reactions/principles). I realize that Corey and Woodward both won for 'body of work' reasons, but they have plently of core contributions as well.


A lot of this begins to sound like the argument as to which baseball player should be awarded Hall of Fame status. If KCN were a baseball player, who would he be?

Permalink to Comment

6. Derek Lowe on October 3, 2005 11:26 AM writes...

Novice, I'm with you. I cannot make a plausible case for Nicolau, not at all. If he were a baseball player, he would be. . .Dave Kingman?

Permalink to Comment

7. patentobserver on October 3, 2005 1:19 PM writes...

I've wondered for years why not Carl Djerassi. Seems to me that even the controversy would be the kind seen recently for the peace prize.

Permalink to Comment

8. Riskssr on October 3, 2005 2:55 PM writes...

I believe Lerner and Schultz are most likely to receive the Prize this year (higher than 35 percent probability). Their work in catalytic antibodies encompanses both chemistry and biology.

Harry Gray is likely to be awarded the prize sometime in the following five years. Lerner and Gray are two of the very few chemists who are foreign members of the Royal Society of Sweden.

I would think that contributions in combinatorial chemistry would also have a chance.

Disclosure: I am not a real chemist. I only play one on tv.

Permalink to Comment

9. anon on October 4, 2005 11:14 PM writes...

Neither Lerner nor Schultz spend much time on catalytic antibodies anymore. Surely they don't give a prize for starting something you're not that interested in continuing.

Permalink to Comment

10. anonymus on October 5, 2005 5:43 AM writes...

grubbs + schrock + chauvin

Permalink to Comment

11. quickened on November 19, 2005 8:44 AM writes...

http://freepages.kconline.com/listrak/having.html brotherlessriver

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Molecular Printing of Drug Molecules. Say What?
Pfizer Walks Again By Night
Gitcher SF5 Groups Right Here
Changing A Broken Science System
One and Done
The Latest Protein-Protein Compounds
Professor Fukuyama's Solvent Peaks
Novartis Gets Out of RNAi